KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Gross Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Gross Margin for 16 consecutive years, with 39.68% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 12932.0% to 39.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 64.56%, a 2208.0% decrease, with the full-year FY2025 number at 64.56%, down 255.0% from a year prior.
  • Gross Margin was 39.68% for Q4 2025 at Biolife Solutions, down from 90.99% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 182.43% in Q4 2023 to a low of 39.68% in Q4 2025.
  • A 5-year average of 85.36% and a median of 87.3% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: soared 9195bps in 2023, then plummeted -12932bps in 2025.
  • Biolife Solutions' Gross Margin stood at 87.19% in 2021, then grew by 4bps to 90.48% in 2022, then surged by 102bps to 182.43% in 2023, then plummeted by -51bps to 89.63% in 2024, then plummeted by -144bps to 39.68% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Gross Margin are 39.68% (Q4 2025), 90.99% (Q3 2025), and 89.25% (Q2 2025).